~~<i id='B8348E5305'><strike id='B8348E5305'><tt id='B8348E5305'><pre id='B8348E5305'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：explore 2025-10-04 07:30:19 - browse：9764

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Florida health officials providing scant details on measles cases

focus

hotspot

knowledge

leisure time

Wikipedia

AxovantSciences(AXON)isthemaineventinbiotech’sSeptembercavalcadeofclinicaltrialreadouts,butwhilewewa

WSS

CDC Director Mandy Cohen on transparency, trust, and health

UHS says company favors patients whose insurance pays more

Democrats decry new health bill for going easy on private equity

Readout Newsletter: BridgeBio, Akero, and human embryo models

Rise in cancer among younger people worries and puzzles doctors

Why patients can’t get everything they want on drug pricing

hotspot

fashion

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How doctors’ personal politics affect patients

After affirmative action ruling, medical educators look to 'holistic review'

IVF doctors demand details after CooperSurgical lawsuit

State Dept. review finds Biden bears some blame for Afghanistan failures

UHS says company favors patients whose insurance pays more

Medical leaders decry Supreme Court decision on affirmative action

Change Healthcare: What is it, why does its cyberattack matter?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The battle over 'scope creep' and who gets to be called 'doctor'

hotspot

Ozempic has benefits for kidney disease as well as diabetes

Fetal cell organoids grown from amniotic fluid, study finds

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Microsoft's Peter Lee: Generative AI could help doctors be more human

Truvian presents data for its desktop blood

Device maker Teleflex to acquire urology company for $600M

knowledge

leisure time

Wikipedia

Wikipedia